A spectrum of developmental disorders that includes autism, and Asperger syndrome. Signs and symptoms include poor communication skills, defective social interactions, and repetitive behaviors.
Comprehensive, easy-to-understand information about this condition
How we create this content →Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Consider asking your healthcare providers these condition-specific questions
European rare disease database
The documentation surrounding autism spectrum disorder is limited due to its complex and heterogeneous nature. As ASD affects a diverse population, systematic clinical studies have been challenging to conduct. The absence of identified genetic markers and established inheritance patterns further complicates the understanding of this condition. Additionally, the variability in symptoms and their expression among individuals makes it difficult to create a comprehensive clinical profile.
To navigate autism spectrum disorder, consider consulting with specialists such as developmental pediatricians or child psychologists with experience in ASD. These professionals can provide tailored assessments and interventions. Additionally, you can reach out to organizations like the Geneva Centre for Autism (https://autism.net) and the Global and Regional Asperger’s Syndrome Partnership (GRASP) (https://grasp.org) for support and resources. Participating in patient registries or natural history studies may also provide valuable insights and contribute to ongoing research efforts.
Currently, Fluoxetine has been designated as an orphan drug for autism spectrum disorder and is in development. There are also 607 active clinical trials exploring various interventions and approaches to manage ASD. For more information on ongoing studies, you can visit ClinicalTrials.gov and search for autism spectrum disorder: https://clinicaltrials.gov/search?cond=autism%20spectrum%20disorder. This research landscape offers hope for future treatment options and better understanding of the disorder.
Actionable guidance for navigating care for autism spectrum disorder
To navigate autism spectrum disorder, consider consulting with specialists such as developmental pediatricians or child psychologists with experience in ASD. These professionals can provide tailored assessments and interventions. Additionally, you can reach out to organizations like the Geneva Centre for Autism (https://autism.net) and the Global and Regional Asperger’s Syndrome Partnership (GRASP) (https://grasp.org) for support and resources. Participating in patient registries or natural history studies may also provide valuable insights and contribute to ongoing research efforts.
Consider asking your healthcare providers these condition-specific questions
Connect with organizations supporting the autism spectrum disorder community
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 8, 2026
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Consider asking your healthcare providers these condition-specific questions
European rare disease database
1 peer-reviewed source from PubMed
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning autism spectrum disorder
Updated Feb 6, 2026
The National Institutes of Health has submitted a request for review to the Office of Management and Budget regarding the information collection for Autism Spectrum Disorder research. This is part of compliance with the Paperwork Reduction Act.
The CDC is seeking public comments on a proposed information collection project aimed at promoting resources for autistic teens and young adults. This initiative aligns with the Paperwork Reduction Act of 1995 and aims to enhance the utility of government information.
A recent systematic review confirms that the use of paracetamol during pregnancy does not increase the risk of autism, ADHD, or intellectual disability. The EMA maintains that paracetamol is a crucial option for managing pain or fever in pregnant women based on extensive scientific data.
The CDC held a media briefing discussing autism spectrum disorder, focusing on awareness and public health initiatives. This event aims to enhance understanding and support for individuals affected by autism.
CDC reports that 1 in 68 children, or 14.7 per 1,000 eight-year-olds, has been identified with autism spectrum disorder. This statistic highlights the ongoing need for awareness and resources for affected families.